USD 224.09
(-0.69%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 | 2.42 Billion USD | 13.38% |
2023 | 4.27 Billion USD | 2.46% |
2022 | 4.28 Billion USD | -10.97% |
2021 | 4.25 Billion USD | 30.01% |
2020 | 2.97 Billion USD | -12.33% |
2019 | 3.36 Billion USD | 72.89% |
2018 | 3.73 Billion USD | 41.71% |
2017 | 2.58 Billion USD | -15.48% |
2016 | 2.57 Billion USD | 42.58% |
2015 | 2 Billion USD | -7.3% |
2014 | 2.15 Billion USD | 27.17% |
2013 | 1.84 Billion USD | -18.92% |
2012 | 2.11 Billion USD | -11.04% |
2011 | 2.19 Billion USD | 5.52% |
2010 | 2.1 Billion USD | 1.69% |
2009 | 2.08 Billion USD | -17.11% |
2008 | 2.03 Billion USD | 7.58% |
2007 | 1.76 Billion USD | 28.92% |
2006 | 1.46 Billion USD | 2.78% |
2005 | 1.41 Billion USD | 14.04% |
2004 | 1.14 Billion USD | 13.94% |
2003 | 1.09 Billion USD | 7.94% |
2002 | 971.05 Million USD | 5.23% |
2001 | 951.58 Million USD | 15.09% |
2000 | 860.57 Million USD | -1.99% |
1999 | 779.7 Million USD | 3.83% |
1998 | 725.1 Million USD | 27.03% |
1997 | 660.3 Million USD | 2.66% |
1996 | 631.8 Million USD | 3.84% |
1995 | 604.4 Million USD | 19.31% |
1994 | 528.8 Million USD | 12.28% |
1993 | 460.2 Million USD | -10.61% |
1992 | 498.2 Million USD | 10.48% |
1991 | 463.6 Million USD | 5.08% |
1990 | 441.2 Million USD | 16.78% |
1989 | 377.8 Million USD | 8.47% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q3 | 1.28 Billion USD | -9.33% |
2024 Q2 | 1.4 Billion USD | 29.15% |
2024 Q1 | 439 Million USD | 36.47% |
2023 FY | - USD | 2.46% |
2023 Q3 | 1.23 Billion USD | -3.22% |
2023 Q4 | 1.02 Billion USD | -17.14% |
2023 Q2 | 1.27 Billion USD | 6.53% |
2023 Q1 | 1.19 Billion USD | 139.28% |
2022 Q4 | 499 Million USD | -55.0% |
2022 FY | - USD | -10.97% |
2022 Q1 | 732 Million USD | 67.89% |
2022 Q2 | 1.21 Billion USD | 65.44% |
2022 Q3 | 1.1 Billion USD | -8.42% |
2021 Q1 | 1.88 Billion USD | 110.29% |
2021 Q2 | 1.03 Billion USD | -44.73% |
2021 FY | - USD | 30.01% |
2021 Q4 | 436 Million USD | -64.29% |
2021 Q3 | 1.22 Billion USD | 17.52% |
2020 Q3 | 457 Million USD | -51.69% |
2020 Q1 | 1.14 Billion USD | 252.62% |
2020 Q4 | 894 Million USD | 95.62% |
2020 FY | - USD | -12.33% |
2020 Q2 | 946 Million USD | -17.45% |
2019 FY | - USD | 72.89% |
2019 Q3 | 1.28 Billion USD | 52.74% |
2019 Q4 | 325 Million USD | -74.61% |
2019 Q2 | 838 Million USD | -45.97% |
2019 Q1 | 1.55 Billion USD | 110.73% |
2018 Q4 | 736 Million USD | -52.61% |
2018 FY | - USD | 41.71% |
2018 Q3 | 1.55 Billion USD | 81.64% |
2018 Q2 | 855 Million USD | -6.66% |
2018 Q1 | 916 Million USD | 54.47% |
2017 Q2 | 784 Million USD | -32.88% |
2017 FY | - USD | -15.48% |
2017 Q4 | 593 Million USD | 287.58% |
2017 Q1 | 1.16 Billion USD | 128.57% |
2017 Q3 | 153 Million USD | -80.48% |
2016 Q2 | 579 Million USD | 19.63% |
2016 FY | - USD | 42.58% |
2016 Q3 | 887 Million USD | 53.2% |
2016 Q4 | 511 Million USD | -42.39% |
2016 Q1 | 484 Million USD | 1.68% |
2015 Q3 | 551 Million USD | 28.44% |
2015 Q1 | 384 Million USD | -6.8% |
2015 Q2 | 429 Million USD | 11.72% |
2015 FY | - USD | -7.3% |
2015 Q4 | 476 Million USD | -13.61% |
2014 Q4 | 412 Million USD | -9.65% |
2014 Q1 | 393 Million USD | 318.09% |
2014 Q2 | 396 Million USD | 0.76% |
2014 Q3 | 456 Million USD | 15.15% |
2014 FY | - USD | 27.17% |
2013 Q4 | 94 Million USD | -77.27% |
2013 Q2 | 395.2 Million USD | -1.38% |
2013 Q1 | 400.72 Million USD | 0.89% |
2013 FY | - USD | -18.92% |
2013 Q3 | 413.63 Million USD | 4.66% |
2012 Q3 | 572.94 Million USD | 35.41% |
2012 Q2 | 423.11 Million USD | -16.98% |
2012 Q1 | 509.63 Million USD | -10.9% |
2012 FY | - USD | -11.04% |
2012 Q4 | 397.19 Million USD | -30.68% |
2011 FY | - USD | 5.52% |
2011 Q4 | 571.95 Million USD | -6.24% |
2011 Q3 | 610.02 Million USD | 34.1% |
2011 Q2 | 454.9 Million USD | -17.51% |
2011 Q1 | 551.49 Million USD | 11.66% |
2010 FY | - USD | 1.69% |
2010 Q3 | 442.19 Million USD | 0.47% |
2010 Q2 | 440.14 Million USD | -3.22% |
2010 Q1 | 454.8 Million USD | -20.48% |
2010 Q4 | 493.88 Million USD | 11.69% |
2009 Q4 | 571.97 Million USD | 28.67% |
2009 FY | - USD | -17.11% |
2009 Q3 | 444.53 Million USD | -8.36% |
2009 Q2 | 485.05 Million USD | -8.29% |
2009 Q1 | 528.91 Million USD | 0.88% |
2008 FY | - USD | 7.58% |
2008 Q3 | 531.9 Million USD | 6.9% |
2008 Q4 | 524.3 Million USD | -1.43% |
2008 Q2 | 497.58 Million USD | 4.27% |
2008 Q1 | 477.18 Million USD | 2.43% |
2007 Q3 | 453.08 Million USD | 7.33% |
2007 FY | - USD | 28.92% |
2007 Q4 | 465.87 Million USD | 2.82% |
2007 Q2 | 422.13 Million USD | 33.05% |
2007 Q1 | 317.27 Million USD | -7.34% |
2006 FY | - USD | 2.78% |
2006 Q4 | 342.43 Million USD | -10.18% |
2006 Q3 | 381.23 Million USD | 12.56% |
2006 Q2 | 338.69 Million USD | -15.74% |
2006 Q1 | 401.97 Million USD | 10.76% |
2005 FY | - USD | 14.04% |
2005 Q4 | 362.91 Million USD | 1.43% |
2005 Q3 | 357.79 Million USD | 0.56% |
2005 Q2 | 355.78 Million USD | 2.16% |
2005 Q1 | 348.24 Million USD | 3.23% |
2004 Q1 | 258.73 Million USD | -14.94% |
2004 FY | - USD | 13.94% |
2004 Q4 | 337.33 Million USD | 4.4% |
2004 Q3 | 323.1 Million USD | -2.12% |
2004 Q2 | 330.1 Million USD | 27.58% |
2003 Q3 | 265.96 Million USD | -5.86% |
2003 Q4 | 305.12 Million USD | 13.5% |
2003 FY | - USD | 7.94% |
2003 Q2 | 282.83 Million USD | 18.82% |
2003 Q1 | 239.66 Million USD | -16.38% |
2002 Q4 | 272.53 Million USD | 12.36% |
2002 Q3 | 244.72 Million USD | -1.2% |
2002 Q2 | 248.65 Million USD | 19.36% |
2002 FY | - USD | 5.23% |
2002 Q1 | 214.61 Million USD | -16.38% |
2001 FY | - USD | 15.09% |
2001 Q3 | 243.96 Million USD | -2.86% |
2001 Q1 | 197.79 Million USD | -28.99% |
2001 Q4 | 258.62 Million USD | 1.48% |
2001 Q2 | 256.89 Million USD | 38.37% |
2000 FY | - USD | -1.99% |
2000 Q3 | 224.61 Million USD | 7.83% |
2000 Q1 | 194.1 Million USD | -6.47% |
2000 Q2 | 225.22 Million USD | -5.11% |
2000 Q4 | 222.95 Million USD | 35.6% |
1999 Q3 | 191.9 Million USD | 28.8% |
1999 Q2 | 210.3 Million USD | 20.92% |
1999 Q1 | 173.6 Million USD | -18.0% |
1999 FY | - USD | 3.83% |
1999 Q4 | 204 Million USD | -23.47% |
1998 Q4 | 209.4 Million USD | -16.53% |
1998 FY | - USD | 27.03% |
1998 Q3 | 159.5 Million USD | 24.05% |
1998 Q2 | 200.2 Million USD | 28.43% |
1998 Q1 | 156.1 Million USD | -18.11% |
1997 Q2 | 173 Million USD | 29.15% |
1997 Q1 | 136.2 Million USD | -24.61% |
1997 FY | - USD | 2.66% |
1997 Q4 | 192.9 Million USD | 25.19% |
1997 Q3 | 158.2 Million USD | -9.02% |
1996 Q3 | 218.9 Million USD | 36.43% |
1996 Q4 | 177.2 Million USD | -21.52% |
1996 Q1 | 123 Million USD | -25.2% |
1996 Q2 | 163.6 Million USD | 31.5% |
1996 FY | - USD | 3.84% |
1995 Q2 | 157.8 Million USD | 43.94% |
1995 Q4 | 174.6 Million USD | -3.61% |
1995 FY | - USD | 19.31% |
1995 Q1 | 109.9 Million USD | -1.59% |
1995 Q3 | 162.1 Million USD | 7.18% |
1994 Q4 | 143.2 Million USD | -22.32% |
1994 Q2 | 143.5 Million USD | 43.74% |
1994 Q1 | 98.7 Million USD | -3.73% |
1994 FY | - USD | 12.28% |
1994 Q3 | 143.2 Million USD | -1.75% |
1993 Q4 | 104.2 Million USD | -12.86% |
1993 Q3 | 130.1 Million USD | 3.28% |
1993 Q2 | 127.3 Million USD | 12.69% |
1993 Q1 | 98.9 Million USD | -33.21% |
1993 FY | - USD | -10.61% |
1992 Q1 | 83.4 Million USD | -35.39% |
1992 Q4 | 153.7 Million USD | 17.02% |
1992 FY | - USD | 10.48% |
1992 Q2 | 127.5 Million USD | 53.96% |
1992 Q3 | 133.7 Million USD | 3.6% |
1991 Q4 | 129.8 Million USD | 11.1% |
1991 Q1 | 90.5 Million USD | -36.54% |
1991 Q3 | 118.6 Million USD | -4.07% |
1991 Q2 | 124.6 Million USD | 40.25% |
1991 FY | - USD | 6.41% |
1990 FY | - USD | 16.43% |
1990 Q1 | 76 Million USD | 106.73% |
1990 Q2 | 113.8 Million USD | 61.74% |
1990 Q3 | 111 Million USD | -6.0% |
1990 Q4 | 140.5 Million USD | 27.84% |
1989 Q2 | 462.9 Million USD | 13.99% |
1989 FY | - USD | 16.43% |
1989 Q3 | 442.8 Million USD | -4.34% |
1989 Q1 | 406.1 Million USD | 140.82% |
1989 Q4 | -1.05 Billion USD | -338.46% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Alcon Inc. | 2.39 Billion USD | -1.336% |
AptarGroup, Inc. | 663.83 Million USD | -265.301% |
Baxter International Inc. | 2.77 Billion USD | 12.644% |
Bausch + Lomb Corporation | 586 Million USD | -313.823% |
Haemonetics Corporation | 262.09 Million USD | -825.226% |
Envista Holdings Corp | 171.1 Million USD | -1317.3% |
ResMed Inc. | 1.6 Billion USD | -51.531% |
Teleflex Incorporated | 792.26 Million USD | -206.086% |
Warby Parker Inc. | -30.21 Million USD | 8126.612% |
West Pharmaceutical Services, Inc. | 847.8 Million USD | -186.034% |